Cite
HARVARD Citation
Caminati, M. et al. (2019). Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response. Expert review of respiratory medicine. pp. 1205-1212. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Caminati, M. et al. (2019). Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response. Expert review of respiratory medicine. pp. 1205-1212. [Online].